American Virtual Cloud Technologies (AVCT) –
-
Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9,
-
ALS-6000-101 Phase 1a Three-Weekly Dose Escalation Safety Study Data
-
Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board
-
Avacta Announces Successful Completion of Fifth Dose Escalation in AVA6000 Phase 1 Clinical Study
-
First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study
-
Avacta Announces First Patient Dosed in Fifth Cohort of AVA6000 Phase Ia Dose Escalation Study
-
Avacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics Division
-
Form SC 13G/A American Virtual Cloud Filed by: Hudson Bay Capital Management LP
-
Form 25-NSE American Virtual Cloud Filed by: Nasdaq Stock Market LLC
-
Form 8-K American Virtual Cloud For: Jan 11
-
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.80%
-
Form 8-K American Virtual Cloud For: Jan 06
-
American Virtual Cloud Technologies (AVCT) Halted, News Pending
-
Form 3 American Virtual Cloud For: Dec 15 Filed by: Sweet Charles E.
-
Form 8-K American Virtual Cloud For: Dec 15
-
Form 424B3 American Virtual Cloud
-
Form EFFECT American Virtual Cloud
-
American Virtual Cloud Technologies (AVCT) Announces 10M Share Offering by Selling Stockholders
-
Form S-3 American Virtual Cloud
-
Form 10-Q American Virtual Cloud For: Sep 30
-
Form SC 13G American Virtual Cloud Filed by: CVI Investments, Inc.
-
Form 8-K American Virtual Cloud For: Oct 20
-
Form 8-K American Virtual Cloud For: Oct 18
-
Form 424B5 American Virtual Cloud
-
American Virtual Cloud Technologies (AVCT) Halted on Volatility
-
American Virtual Cloud Technologies (AVCT) Announces $10 Million Registered Direct Offering and Concurrent Private Placement of Common Stock, Warrants
-
AVCT Announces $10 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
-
AVCT Announces $10 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
-
Form 8-K American Virtual Cloud For: Oct 11
-
Form 8-K American Virtual Cloud For: Sep 30
-
Increasing unusual option volume: AVCT ICPT INDA RETA VYM AMLX
-
AVCT (AVCT) Announces Intent to Effect 1-for-15 Reverse Stock Split
-
AVCT Announces Intent to Effect Reverse Stock Split
-
AVCT Announces Intent to Effect Reverse Stock Split
-
Implied Volatility Movement
-
Implied Volatility Movement
-
Increasing unusual option volume: AVCT CSTM IMAX TCDA ATUS
-
Increasing unusual option volume: AVCT TCDA DNMR CC NGD REM CRHC
-
Form 8-K American Virtual Cloud For: Sep 26
-
Implied Volatility Movement
-
Increasing unusual option volume: AVCT PLTK PTEN ZEN FREY PRPL
-
Form 4 American Virtual Cloud For: Aug 29 Filed by: Ribbon Communications Inc.
-
Form SC 13D/A American Virtual Cloud Filed by: Ribbon Communications Inc.
-
Implied Volatility Movement
-
Form 8-K American Virtual Cloud For: Sep 11
-
Implied Volatility Movement
-
Form 8-K American Virtual Cloud For: Sep 07
-
Avacta Announces AVA6000 Receives Orphan Drug Designation From the US Food and Drug Administration
-
Increasing unusual option volume: AVCT NTNX DXC BBW XME OKTA FIVE
-
Form 8-K American Virtual Cloud For: Sep 01
Back to AVCT Stock Lookup